Supporting Figures and
. Optimisation of the on-resin alkylation of 2 with imidazole. All the reactions were done under µw heating (60 °C, 25W, 40 min) using a Biotage® Initiator + SP Wave peptide synthesizer. At the end of the reaction, the compound was cleaved off the resin with 30% HFIP in DCM (45 min) for analysis by HPLC or 1 H NMR. S3   Table S2 . Optimisation of the on-resin alkylation of 3 with 2-(bromomethyl)pyridine hydrobromide High Resolution Mass Spectra (HRMS) were performed on a Bruker microTOF2 spectrometer by direct infusion.
Analytical RP-HPLC was performed using an Agilent Technologies 1100 modular HPLC system coupled to a Polymer Lab 1000 Evaporative Light Scattering Detector (ELSD) and multi-wavelength detector equipped with a Phenomenex Kinetex® XB-C18 100 Å LC Column (50 × 4.6 mm, 5 µm), eluting with a gradient of H2O/formic acid (0.1%) to ACN/formic acid (0.1%) over 10 min, with a flow rate of 1 mL/min. Semi-preparative RP-HPLC was performed with an Agilent Zorbax Eclipse® 5µm XDB-C18 column (250 × 10 mm, 5 µm), eluting with a gradient of H2O/formic acid (0.1%) to ACN/formic acid (0.1%) over 25 min, with a flow rate of 2 mL/min.
Fluorescent kinetic assays were monitored on a BioTek SynergyHT plate reader. Confocal images were obtained on a Leica SP5 confocal microscope and ImageJ was used for analysis.
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Solid phase synthesis of NHC-Pd catalysts 5-12
Detailed protocol for the synthesis of catalyst 5 with a 6-aminohexanoic acid spacer.
Synthesis of Fmoc-Ahx-OH loaded 2-chlorotrityl-linker PS-resin 1
426 mg of the 2-chlorotrityl chloride linker on polystyrene resin (loading 1 mmol/g according to the supplier, 100-200 mesh) was swollen in anhyd. DCM (5 mL) and subsequently re-activated with SOCl2 (2.5 eq.) in anhyd. DCM (3.5 mL) under N2 atm for 1 h. The resin was drained and washed with anhyd. DMF (3 × 5 mL) and anhyd. DCM (3 × 5 mL). Fmoc-Ahx-OH (451 mg, 3 eq., 0.4 M) in 3 mL of anhyd. DCM/DMF (9:1) was added to the resin, followed by DIPEA (444 µL, 6 eq.), and the reaction was stirred for 1 h. The resin was washed with anhyd. DMF (3 × 5 mL) and anhyd. DCM (3 × 5 mL). The resin was capped with a mixture of DCM/MeOH/DIPEA (8:1.5:0.5) for 2 × 15 min. The Fmoc deprotection was carried out using 20% piperidine in DMF (2 × 10 min) and the resin washed thoroughly with DMF and DCM.
Coupling to resin 1
Resin 1 (426 mg) was loaded into a 10 mL SP wave reaction cartridge. 1 M DIC (469 µL, 3 mmol) was added to 2M bromoacetic acid (886 mg, 6.5 mmol) in anhyd. DMF (3 mL) and, after mixing, the solution was added to the resin.
The reaction was heated at 60 °C (µw) for 20 min. The resin was washed thoroughly with DMF (5 × 2 mL) and DCM (5 × 2 mL). For compound characterisation, a small portion of the resin was treated with 30% HFIP in DCM for 45 min. The liquid was collected and the resin was rinsed with a small portion of the cleavage solution and the solvent evaporated to dryness in vacuo. 
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Alkylation of resin 2
Resin 2 (400 mg) was loaded into a 10 mL SP wave reaction cartridge. AgNO3 (253 mg, 1.5 mmol) in DMSO (1 mL) was added to a 2 M solution of imidazole (408 mg, 6 mmol) in DMSO (2 mL). The solution was added to the resin and the reaction was heated at 60 °C (µw) for 40 min. The resin was washed with DMF (5 × 5 mL) and DCM (5 × 5 mL). For compound characterisation, a small portion of the resin was treated with 30% HFIP in DCM for 45 min. The liquid was collected and the resin was rinsed with a small portion of the cleavage solution and the solvents evaporated to dryness in vacuo. 166.5, 139.4, 128.7, 124.6, 121.8, 52.0, 40.4, 29.9, 27.5, 25.9 .
Alkylation of resin 3
Resin 3 (380 mg) was loaded into a 10 mL SP wave cartridge. To 2-(bromomethyl) pyridine hydrobromide salt (750 mg, 3 mmol) and Et3N (550 µL, 4 mmol) in anhyd. DMF (2.25 mL), AgNO3 (253 mg, 1.5 mmol) in anhyd. DMF (0.75 mL) was added, and the solution was mixed thoroughly and gently heated until homogeneous solution was obtained. This solution was added to the resin and heated at 60 °C (µw) for 90 min. The resin was washed with 20% piperidine in DMF (3 × 5 mL), DMF (5 × 5 mL) and DCM (5 × 5 mL), and dried. The resin was transferred to a clean SP wave cartridge ensuring that no black precipitate (silver oxide or silver nanoparticles) remained. Anhyd. DMF (200 µL) was added to the resin, followed by 2-tert-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine (BEMP) (2.5 equiv., 0.5 mmol), and the reaction mixture was stirred 45 min at room temperature under N2 atm. Pd(COD)Cl2 (1.5 equiv.
0.3 mmol) in DMF (100 µL) was added and the reaction was stirred for 16 h. The resin was washed with DMF (5 × 3 mL) and DCM (5 × 3 mL). The catalyst was cleaved from the resin with 5% TFA in DCM for 30 min. The filtrate was collected, evaporated under a flow of N2 and purified by semi-preparative HPLC.
Synthesis of the catalyst library
The reactions were done on a ~ 0.25 mmol scale (~ 250 mg resin). For the synthesis of catalysts 6-12, the appropriate N-Fmoc protected amino acids/spacers were loaded onto the 2-chlorotrityl chloride linker and the ligand built as described above for catalyst 5. For catalyst 12 with the Phe-Trp-Ahx sequence, the amino acid couplings were carried out as follows. Fmoc-protected amino acid (3 eq., 0.25 M) in DMF was stirred at rt with DIC (3 eq. 0.25 M) for 5 min, followed by addition of Oxyma (3 eq. 0.25 M) and stirred for additional 10 min. The activated Fmoc-amino acid was added to the resin and coupling reactions were carried out at 60 °C for 20 min under µw irradiation. The resin was washed with DMF (3 × 5 mL), DCM (3 × 5 mL) and MeOH (3 × 5 mL). Next, the pre-swollen resin (in DCM) was treated with 20% piperidine in DMF (2 × 10 min). The resin washed thoroughly with DMF (3 × 5 mL) and DCM (3 × 5 mL).
Characterisation of the ligands for catalysts 5-12
For compound characterisation, a small sample of the ligand was cleaved off the resin with 30% HFIP prior to palladium loading. The analytical samples were purified by semi-preparative HPLC. , 2H), 1.65 -1.57 (m, 2H), 1.57 -1.50 (m, 2H), 1.40 -1.30 (m, 6H) .
13 C NMR (126 MHz, Methanol-d4) δ 179. 9, 169.8, 154.3, 151.1, 139.2, 125.3, 125.1, 124.1, 123.9, 54.9, 52.0, 40.8, 36.7, 30.2, 30.1, 29.9, 27.6, 26.6 2, 151.0, 139.7, 139.2, 130.4, 129.2, 127.4, 125.3, 124.9, 124.1, 123.7, 57.8, 54 .9, 52.1, 39.3. HRMS (ESI) calculated 366.1686 for C20H22N4O3; found 366.1669;
HPLC tR 3.6 min (254 nm).
Ligand for catalyst 11
1 H NMR (500 MHz, Methanol-d4) δ 9.18 -9.15 (m, 0, 166.8, 154.2, 151.0, 139.6, 139.2, 125.3, 125.1, 124.2, 123.9, 54.9, 54.0, 51.8, 40.4, 32.2, 28.0, 23.8 . HRMS (ESI) calculated 346.1873 for C17H24N5O3; found 346.1858; HPLC 0.6 min (254 nm). 2, 172.7, 169.9, 154.1, 151.1, 139.2, 138.0, 138.0, 130.3, 129.6, 128.8, 127.9, 125.3, 124.9, 124.7, 124.1, 123.8, 122.5, 119.8, 119.4, 112.4, 110.7, 56.7, 55.9, 54.9, 40.3, 38.6, 37.1, 29.7, 29 .1, 27.5, 26.5. HRMS (ESI) calculated 665.3310 for C37H43N7O5; found 665.3320; HPLC tR 4.4 min (254 nm).
Catalyst synthesis on a Rink-amide functionalised resin
Catalyst 13 was synthesised on Rink-amide functionalised polystyrene resin to demonstrate the adaptability of the synthetic protocol. Fmoc-Rink Amide linker (3 eq. 0.75 M) and DIC (3 eq. 0.75 M) were stirred in DMF for 5 min, followed by addition of Oxyma (3 eq. 0.75 M) and stirring for an additional 10 min. This solution was added to 300 mg of preswollen aminomethyl polystyrene resin (loading 0.745 mmol/g, 200-400 mesh) and the mixture shaken at room temperature for 2 h. The resin was washed with DMF (3 × 5 mL), DCM (3 × 5 mL) and MeOH (3 × 5 mL).
Following this, the Fmoc group was deprotected with 20% piperidine in DMF (2 × 10 min) and the resin was washed with DMF (3 × 5 mL) and DCM (3 × 5 mL). Subsequent amino acids were coupled (Fmoc-Val-OH and Fmoc-Phe-OH) and the NHC-palladium ligand synthesised on resin as described for 5. 0, 173.9, 173.8, 166.7, 154.2, 151.0, 139.4, 139.2, 138.1, 130.3, 129.57, 127.9, 125.3, 125.1, 124.2, 123.9, 60.9, 56.5, 55.0, 51.8, 43.1, 38.9, 31.7, 19.7, 18 .8.
HRMS (ESI) calculated 520.2667 for C27H34N7O4; found 520.2673; HPLC; tR 3.3 min (254 nm).
Catalyst screening
Stock solutions (20 µM) of the probe DCF-1 2 were prepared in 5% acetonitrile either in PBS or in MCF-7 cell lysate.
The catalyst solutions were freshly prepared either in PBS or in MCF-7 lysate. The screenings were carried out on black 96-well plates. 50 µL of the probe DCF-1 (to give a working concentration of 10 µM) was added per well, followed by 50 µL of the catalyst solution (0.8 mol%) and the increase in fluorescence (λEx/Em 485/520 nm) at 37 °C recorded over time (4 h or 12 h) on a plate reader (n = 3). The relative increase in fluorescence was compared with the blank and the control experiment (PBS or cell lysate).
Stability of Catalysts
Catalysts 8, 9 and 12 (~ 1 mg/mL) were stored in H2O/ACN (9:1) at 4 °C for 2 months. Following this, the samples were analysed by analytical HPLC. S17
Prodrug activation in MCF-7 cells
MCF-7 cells (from the European Collection of Authenticated Cell Cultures (ECACC)) were grown in Dulbecco's modified eagle medium (DMEM) supplemented with 10% FBS, 1% penicillin/streptomycin and 200 nM L-glutamine in a humidified incubator at 37 °C with 5% CO2. Cells were cultured in T-75 flasks (Corning) to ≥ 80% confluence.
Cells were harvested with trypsin/EDTA (Gibco.)
The MCF-7 cells (8 × 10 3 cells/well) were seeded on 96-well plates and grown to ~60% confluence overnight. Control cells were treated with 100 µM of 5-FU (with 1% DMSO), 100 µM Pro-5-FU (with 1% DMSO), and 10 µM and 50
µM of catalyst 8. The cells for prodrug activation were treated first with 100 µM of Pro-5-FU for 1 day and followed by addition of 10 mol% (Pd) of catalyst 8, and the cells were incubated for 4 days under standard cell culture conditions. The cells were washed with PBS, followed by the addition of the MTT reagent and incubated for 3 h.
The formazan crystals formed were dissolved in MTT dissolving solution (isopropanol and Triton-X 100 (9:1) acidified with conc. HCl) and the absorbance measured on a plate reader at 570 nm. The results were compared with untreated cells and expressed as percentage of cell viability. 
Prodrug activation in MCF-
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The following HPLC traces were used to confirm the stability of Pd catalysts 8, 9, 12 at 254 nm. Catalysts 8, 9 and 12 were stored at 4 °C for 1 month in a solution of H2O/ACN and no degradation was observed. 
